Literature DB >> 8373348

Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C.

S E Wilkinson1, P J Parker, J S Nixon.   

Abstract

The protein kinase C (PKC) family of isoenzymes is believed to mediate a wide range of signal-transduction pathways in many different cell types. A series of bisindolylmaleimides have been evaluated as inhibitors of members of the conventional PKC family (PKCs-alpha, -beta, -gamma) and of a representative of the new, Ca(2+)-independent, PKC family, PKC-epsilon. In contrast with the indolocarbazole staurosporine, all the bisindolylmaleimides investigated showed slight selectivity for PKC-alpha over the other isoenzymes examined. In addition, bisindolylmaleimides bearing a conformationally restricted side-chain were less active as inhibitors of PKC-epsilon. Most noticeable of these was Ro 32-0432, which showed a 10-fold selectivity for PKC-alpha and a 4-fold selectivity for PKC-beta I over PKC-epsilon.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373348      PMCID: PMC1134458          DOI: 10.1042/bj2940335

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  K252a is a potent and selective inhibitor of phosphorylase kinase.

Authors:  L H Elliott; S E Wilkinson; A D Sedgwick; C H Hill; G Lawton; P D Davis; J S Nixon
Journal:  Biochem Biophys Res Commun       Date:  1990-08-31       Impact factor: 3.575

2.  Expression of protein kinase C isotypes using baculovirus vectors.

Authors:  S Stabel; D Schaap; P J Parker
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

Review 3.  Protein kinase C.

Authors:  S Stabel; P J Parker
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

4.  Protein kinase C contains a pseudosubstrate prototope in its regulatory domain.

Authors:  C House; B E Kemp
Journal:  Science       Date:  1987-12-18       Impact factor: 47.728

5.  Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity.

Authors:  P D Davis; L H Elliott; W Harris; C H Hill; S A Hurst; E Keech; M K Kumar; G Lawton; J S Nixon; S E Wilkinson
Journal:  J Med Chem       Date:  1992-03-20       Impact factor: 7.446

6.  Potent selective inhibitors of protein kinase C.

Authors:  P D Davis; C H Hill; E Keech; G Lawton; J S Nixon; A D Sedgwick; J Wadsworth; D Westmacott; S E Wilkinson
Journal:  FEBS Lett       Date:  1989-12-18       Impact factor: 4.124

7.  Expression, purification, and characterization of protein kinase C-epsilon.

Authors:  D Schaap; P J Parker
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

8.  Expression of protein kinase C genes in hemopoietic cells is cell-type- and B cell-differentiation stage specific.

Authors:  H Mischak; W Kolch; J Goodnight; W F Davidson; U Rapp; S Rose-John; J F Mushinski
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

9.  Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides.

Authors:  P D Davis; C H Hill; G Lawton; J S Nixon; S E Wilkinson; S A Hurst; E Keech; S E Turner
Journal:  J Med Chem       Date:  1992-01       Impact factor: 7.446

10.  Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction.

Authors:  R A Bit; P D Davis; L H Elliott; W Harris; C H Hill; E Keech; H Kumar; G Lawton; A Maw; J S Nixon
Journal:  J Med Chem       Date:  1993-01-08       Impact factor: 7.446

View more
  131 in total

Review 1.  Protein kinase C isoenzymes: a review of their structure, regulation and role in regulating airways smooth muscle tone and mitogenesis.

Authors:  B L Webb; S J Hirst; M A Giembycz
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

2.  Involvement of Rho-kinase in contraction of guinea-pig aorta induced by prostanoid EP3 receptor agonists.

Authors:  Winnie W C Shum; Geng-Yun Le; Robert L Jones; Alison M Gurney; Yasuharu Sasaki
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

3.  Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.

Authors:  Todd M Quinton; Soochong Kim; Carol Dangelmaier; Robert T Dorsam; Jianguo Jin; James L Daniel; Satya P Kunapuli
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

4.  Inhibition of glucose-stimulated insulin secretion by Ro 31-8220, a protein kinase C inhibitor.

Authors:  S J Persaud; P M Jones
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

5.  Extracellular calcium sensing receptor stimulation in human colonic epithelial cells induces intracellular calcium oscillations and proliferation inhibition.

Authors:  Osvaldo Rey; Steven H Young; Rodrigo Jacamo; Mary P Moyer; Enrique Rozengurt
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

6.  Gender difference in rat aorta vasodilation after acute exposure to high glucose: involvement of protein kinase C beta and superoxide but not of Rho kinase.

Authors:  Aditya Goel; Yingmin Zhang; Leigh Anderson; Roshanak Rahimian
Journal:  Cardiovasc Res       Date:  2007-07-04       Impact factor: 10.787

7.  Involvement of Listeria monocytogenes phosphatidylinositol-specific phospholipase C and host protein kinase C in permeabilization of the macrophage phagosome.

Authors:  Mathilde A Poussin; Howard Goldfine
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

8.  Tyrosine phosphatase antagonist-induced activation of the neutrophil NADPH oxidase: a possible role for protein kinase C.

Authors:  P A Bennett; P M Finan; R J Dixon; S Kellie
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

9.  Regulation of platelet glycoprotein IIb/IIIa (integrin alpha IIB beta 3) function via the thrombin receptor.

Authors:  A N Giesberts; G van Willigen; E G Lapetina; J W Akkerman
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

10.  PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1.

Authors:  Guey-Shin Wang; Muge N Kuyumcu-Martinez; Satyam Sarma; Nitin Mathur; Xander H T Wehrens; Thomas A Cooper
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.